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Abstract
Background: The aim of the study was to explore practitioner-patient interactions and patient responses when
using QRISK®2 or JBS3 cardiovascular disease (CVD) risk calculators. Data were from video-recorded NHS Health
Check (NHSHC) consultations captured as part of the UK RIsk COmmunication (RICO) study; a qualitative study of
video-recorded NHSHC consultations from 12 general practices in the West Midlands, UK. Participants were those
eligible for NHSHC based on national criteria (40–74 years old, no existing diagnoses for cardiovascular-related
conditions, not on statins), and practitioners, who delivered the NHSHC.
Method: NHSHCs were video-recorded. One hundred twenty-eight consultations were transcribed and analysed
using deductive thematic analysis and coded using a template based around Protection Motivation Theory.
Results: Key themes used to frame the analysis were Cognitive Appraisal (Threat Appraisal, and Coping Appraisal),
and Coping Modes (Adaptive, and Maladaptive). Analysis showed little evidence of CVD risk communication,
particularly in consultations using QRISK®2. Practitioners often missed opportunities to check patient understanding
and encourage risk- reducing behaviour, regardless of the risk calculator used resulting in practitioner verbal
dominance. JBS3 appeared to better promote opportunities to initiate risk-factor discussion, and Heart Age and
visual representation of risk were more easily understood and impactful than 10-year percentage risk. However, a
lack of effective CVD risk discussion in both risk calculator groups increased the likelihood of a maladaptive coping
response.
Conclusions: The analysis demonstrates the importance of effective, shared practitioner-patient discussion to
enable adaptive coping responses to CVD risk information, and highlights a need for effective and evidence-based
practitioner training.
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Background
Cardiovascular disease (CVD) is the leading cause of
death worldwide, accounting for one in four deaths in
England [1]. NHS Health Check (NHSHC) is a national
programme designed to screen CVD risk, facilitate early
diagnosis and reduce health inequalities [2]. All eligible
adults, aged 40–74 years, should be invited for NHSHC
where CVD risk is assessed based on several risk factors
(e.g., blood pressure and cholesterol). Best practice
guidance suggests a patient should be given appropriate
CVD risk management advice following effective risk
communication [3]. However, information on the nature
and quality of the consultation is scarce. Insight is
limited to patient and practitioner experiences [4], which
do not provide a complete understanding of patient-
practitioner interactions within the NHSHC.
Communicating risk is challenging [5] and differs
according to patient understanding, numerical literacy,
and personality traits [6]. Further, emotional responses
to risk and the resulting influence on health behaviour
varies between patients [7–10]. If delivered sub optimally,
risk communication can increase anxiety and reduce
confidence in health professionals [11]. Effective risk
communication can improve knowledge, empower and
create autonomy [12–14]. Within NHSHC, 10-year per-
centage risk is calculated and communicated to patients
using a prediction algorithm, QRISK®2 [with current
transference to QRISK®3 [15]], which is populated from
new and pre-existing data within the patient’s record.
However, most younger eligible adults are predisposed
to a lower CVD risk which can lead to false reassur-
ances [16, 17], misinterpretation [18–22], and poor
patient recall and confusion [15]. The 2014 JBS risk
calculator [15] includes Heart Age [23–26, 27] and 10-
year percentage risk, but primarily focuses on lifetime
risk of CVD events through CVD event-free survival
(Table 1). It also presents information using multiple
visual displays (Table 1) [5] and a function to manipu-
late the scores to show how risk-factor modification af-
fects overall risk (e.g., smoking cessation). Whilst there
is some evidence to suggest that lifetime risk, Heart
Age and visual displays may be more effective during
the communication of risk [25, 26, 28–35], until re-
cently, no research has compared the efficacy of JBS3
and QRISK®2 for communicating risk in NHSHC.
Patient-practitioner interactions are complex [36, 37],
yet application of theories such as Protection Motivation
Theory (PMT [36];) have shown how fear of threat can
translate in to health-protective behaviour [38]. Within
PMT, the intention to engage in health-protective
behaviour is influenced by an individual’s cognitive
appraisals (Fig. 1). CVD risk information presented in an
NHSHC can feed into such appraisals, either threat
appraisal (risk of CVD), or coping appraisal (conse-
quences of undertaking positive behaviour change).
Threat appraisal focuses on the source of the threat
(CVD risk) and evaluates the probability of a maladaptive
response (i.e., behaviours that inhibit patients’ ability to ad-
just to the threat). It considers patients’ perceived severity
of CVD risk, the consequences of CVD, perceived vulner-
ability to future CVD and intrinsic and extrinsic rewards
for not addressing CVD risk [i.e., perceived benefits of not
acting to manage or reduce risk (maladaptive response)].
Coping appraisal evaluates the adaptive coping responses
available to the patient to deal with the threat (i.e., evalu-
ation of ways to reduce CVD risk). This includes patients’
perceptions of self-efficacy to engage in adaptive coping,
practitioners’ promotion of self-efficacy through individual-
isation, perceived response efficacy of adaptive coping, and
response cost of adaptive coping (Fig. 1). Both are influ-
enced by intrapersonal (e.g., prior experience of both posi-
tive (adaptive) and negative (maladaptive) behaviours) and
environmental variables (e.g., persuasive communication)
[38]. For NHSHC, PMT highlights the practitioners’ key
role in providing information on CVD risk whilst taking
into account a patients’ experience, priorities and beliefs to
encourage engagement in risk-reducing behaviours [39].
The RIsk COmmunication in NHSHC (RICO) study
involved analysis of video-recorded NHSHC consulta-
tions [40]. Analysis of quantitatively characterised con-
tent of consultations found that compared with JBS3
consultations, those using QRISK®2 were shorter, more
verbally dominated by practitioners and involved less
discussion of CVD risk [41]. This provided the first
insight from objective data on the nature and content of
NHSHC consultations, with comparison between risk
calculators. But the need for more in-depth qualitative
analysis, to explore the quality of interactions around
CVD risk and how this differs by CVD risk calculator,
was clear. This paper uses deductive thematic analysis
Table 1 Features available in each of the risk calculators included in the study
Risk
Calculator
Absolute risk
(10-year percent-age risk)
Relative
risk
Heart
Age
CVD Event-Free
Survival Age
Icon
Arrays
Thermometer
scale
Visual
Analogue
Scale
Bar
Chart
Line
Graph
Risk
Modification
Function
QRISK®2 ✓ ✓ ✓ ✓
QRISK®2 +
Informatica
✓ ✓ ✓ ✓ ✓ ✓ ✓
JBS3 ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
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on a sample of video-recorded consultations, from the
RICO study, which aimed to: explore how practitioners
use QRISK®2 and JBS3 to communicate CVD risk in the
consultation; explore how patients respond to risk
information.
Methods
Design
The RICO study sought to explore the perception and
understanding of CVD risk from both patients and prac-
titioners, when using the JBS3 or QRISK®2 calculator,
the practitioners’ associated advice or offer of treatment
and the patients’ response. Information regarding the
overall study, including recruitment and data collection
is available [40]. In this report, we focus on qualitative
deductive analysis of video-recorded NHSHC consultations.
Participants and recruitment
A detailed description of patient and public engagement
along with participant and practice recruitment is avail-
able elsewhere [41]. To summarise; data were collected
from general practices (n = 12) located in the West
Midlands of England (Jan-17 to Feb-19), supported by
the Clinical Research Network West Midlands. Practices
were matched in pairs, based on deprivation, and assigned
to usual practice (communicated CVD risk using QRIS
K®2) or intervention (communicated CVD risk using JBS3).
Two practices in the QRISK®2 group used Informatica
(supplementary software within in the NHSHC template
that includes Heart Age and risk manipulation similar to
JBS3; Table 1); data were included in the analysis as this
was felt representative of ‘usual care’. Quotations from the
transcripts from these practices are referred to as ‘QRIS
K®2 + Informatica’. Only patients who were eligible for an
NHSHC, based on national criteria, were included in the
study [42]. Postal invitations included a participant infor-
mation sheet and were stratified based on gender, age and
ethnicity for each practice. Practitioners were already
employed by the practice (8 Health Care Assistants
(HCAs), 6 Practice Nurses, 1 Sister) and all but one practi-
tioner already had experience of delivering NHSHC as part
of their job role (a HCA who was new to NHSHC delivery;
1–2 weeks prior to study commencement).
In total, 175 video-recorded NHSHCs were conducted
(range 6.8 to 38min), reduced to 173 following screen-
ing of data (JBS3 = 100; QRISK®2 = 73; practitioner error
resulted in 2 exclusions). To define the sample for quali-
tative analysis, a further 21 Health Checks were excluded
for reasons including: projected (not actual) risk score
communicated (n = 7), no discussion of risk (n = 2), no
communication of lifetime risk (n = 4), incorrect use of
JBS3 (n = 6), insufficient use of English language (n = 2).
Of the remaining sample (n = 154), 64 Health Checks
included communication of CVD risk using QRISK®2.
Therefore, 64 NHSHC using JBS3 were identified,
matched on patients’ gender, ethnicity and CVD risk
score (Table 2), giving a sample of 128 for analysis.
Procedure
Practices video-recorded NHSHCs, communicating
CVD risk using QRISK®2 or JBS3 (following both patient
and practice consent). All consultation dialogue was
transcribed verbatim.
Analysis
Data were analysed using deductive thematic analysis
[43, 44] using a coding template based around Protection
Motivation Theory (PMT [36];) (Supplementary Material 1).
Fig. 1 Protection Motivation Theory model adapted to proposed study context [38]
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Each transcript was uploaded to QSR International’s NVivo
12 qualitative data analysis software [45]. This allowed for
interpretation of how QRISK®2 and JBS3 were used to
communicate risk in the context of PMT components (e.g.,
verbal persuasion, influencing patient prior beliefs and prior-
ities; and how patients respond, which will reflect the nature
of their appraisal within the consultation).
Initially, 14 transcripts were inductively coded inde-
pendently by two Caucasian female researchers, experi-
enced in qualitative research, a senior researcher (LC;
DPsych) and research associate (VR; MSc). The senior
researcher (LC) had previous research experience related
to children’s healthy eating whilst the research associate
(VR) had previous research experience in risk communi-
cation in NHSHC. This was to check the application of
PMT to NHSHC consultations and agree coding be-
tween the researchers. Following inductive coding, 13
new codes were added to the framework (e.g., medical
history, clarification of results). The final version of the
coding template shows how elements of the PMT were
classified including code definitions and examples from
the NHSHC consultations (Supplementary Material 2).
The remaining 114 transcripts were individually coded
by LC and VR; two in every 20 transcripts were inde-
pendently dual-coded to check reliability using Kappa
coefficients for each NVivo node within the PMT frame-
work (i.e., 19th, 20th, 39th, 40th, 59th, 60th etc). Reli-
ability ranged from .48 to .71 over the five reliability
checks conducted, indicating fair to good reliability [46].
Data saturation was considered reached at the point of
completion of coding.
Subsequent analysis of codes was led by SF (Researcher;
MSc) (supported by SG, CG, NE and VR) to identify codes
for key elements of the PMT model, splitting the consulta-
tions into two groups (QRISK®2 and JBS3). Specific parts
of transcripts that illustrated the practitioner communicat-
ing CVD risk to the patient and patient responses were
identified. These related to Cognitive Appraisal (Threat
Appraisal, and Coping Appraisal), and Coping Modes
(Adaptive, and Maladaptive). The focus of the present
analysis was the consultation time spent communicating
CVD risk (across sample approximately 1.7 (±0.83) mi-
nutes) [41], to explore similarities and differences between
the two calculators under investigation. Most patients said
little in response to CVD risk information. Therefore,
where there was evidence of two-way dialogue, we present
quotations that best illustrate risk communication and
subsequent patient response.
Results
Deductive thematic analysis was conducted on 128
video-recorded NHSHC consultations. Patients were
approximately matched by gender, age and ethnicity.
Those in the QRISK®2 group were marginally younger
(Table 2).
Results of the deductive thematic analysis demonstrate
how practitioners communicated risk using either QRIS
K®2 or JBS3. They also present patients’ responses to the
communication of risk, allowing for evaluation of the
two calculators. Each quote is coded to denote which
risk calculator was used, the consultation identifier,
patient gender and age.
Cognitive appraisal
Threat appraisal
Threat appraisal was the most commonly identified
element of the PMT model. It was observed in all con-
sultations, although less frequently in JBS3 consultations
(coded 584 times; average 9/consultation) compared to
QRISK®2 consultations (coded 634 times; average 10/
consultation).
Once presented with a QRISK®2 score, patients ac-
knowledged their risk level, but their understanding of
10-year percentage risk was unclear. For example, one
asked ‘is that percentage of risk alright?’. Generally, the
risk score was acknowledged with a single word re-
sponse, such as ‘yeah’ or ‘okay’, impeding practitioners’
ability to gauge patient understanding and classification
of response for this analysis. Heart Age aided patient un-
derstanding of CVD risk, resulting in questions such as:
“… so really what can I do about that? I mean I know it
is all estimated.” Such questions reflected a level of
understanding of the score and intention to engage in
risk-reducing behaviour. Several patients expressed sur-
prise at their risk. Below, the patient appeared to question
Table 2 Characteristics of patients included in analysis
QRISK®2 JBS3
Gender
Female 32 32
Male 32 32
Total 64 64
Age
40–54 34 21
55–64 17 20
65–74 13 23
Total 64 64
Ethnicity
White British (WBRI) 58 56
Black Asian and Minority Ethnic (BAME) 6 8
Total 64 64
CVD Risk
Low % 43 43
Med-high % 21 21
Total 64 64
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how the score was calculated as they perceived themselves
to be healthier than the outcome suggested, leading to
some mistrust. They also made two references to being
‘fitter’ than the risk score indicated, which was not ad-
dressed by the practitioner:
P I thought I was fitter than that though.
HP (Laughter) You are doing good exercises,
P But I was fitter than that though …
HP OK, so the health years, so on average expect
to survive is 80 for yourself without a heart
attack or a stroke, yeah? And then your risk of
a heart attack or stroke in the next 10 years is
15%, so you do need to look after yourself,
because we would say that is a medium risk.
P Yes
HP So wouldn’t say it is too high or low, but a
medium to high.
P OK
HP OK, and then that’s what it looks like so from
now until there, that’s the last one the chance
of surviving without a heart attack.
P That’s estimated?
HP This is estimated, we don’t know what’s going
to happen you might be even longer.
P So about 94 I might snuff it?
(JBS3, 11_028, Male, 58)
By overlooking the patient’s surprise and perhaps focusing
on the process of NHSHC, the patient momentarily shut
down until they were presented with their CVD event-free
survival age. The concept, included within JBS3, prompted
some misunderstanding among patients and practitioners.
This was perceived by some patients as an estimate of life
expectancy.
Practitioners provided little follow-up risk score
explanation when using QRISK®2 or JBS3.
HP Right, this is the screening I was telling you
about. I will just print that out for you. So your
risk of any heart disease is 15%.
P Yeah, which is not very high.
HP It does increase with age. If it is above 10%
we then pass it on for them to have a look
at it and they will be able to decide when to
have your next health check which should be
3 years or 1 year. Obviously next time you
come in any results you’ve got in the red
tend to up your risk and they tend to up
your Heart Ageas well. So when you come in
next time if your blood pressure is back
down, and obviously it could be less so …
Your Heart Age has come up as 66.
P Well I am 66 this year.
HP Yes, yes, so it is quite near isn’t it?
Yes. So, for example, if you were a smoker and
that was in the red that would put your Heart
Age at 75. So the only one we have got in the
red really is that one cholesterol …
P It’s only marginal though isn’t it
(QRISK®2 + Informatica, 2_016, Male, 65)
Above, the patient was identified as medium-high risk,
but the practitioner did not elaborate on the severity or
implications, leaving the patient’s interpretation of their
risk score as “not very high”. This was compounded
when the patient received their Heart Age. The practi-
tioner did not address the patient’s misinterpretation of
the severity of their risk nor explain why their results are
conflicting, again perhaps focussing more so on the con-
sultation process than the patient. This led the patient to
dismiss their elevated cholesterol as “only marginal”.
The absence of active listening skills was recurrent
across both groups making it difficult to gauge patient
understanding.
Although limited, there was more evidence of active
practitioner-patient engagement in conversation regard-
ing threat of CVD in the JBS3 group following risk score
manipulation (e.g., practitioners visually showed patients
that a reduction in blood pressure, could lower their
Heart Age):
HP … so obviously your blood pressure is not too
bad, that is fine where it is at 128, but your
cholesterol, so ideally we like that to be below 5.
So if you could get it below 5, so lets put it
down to 4.8, you can see that automatically
that it brings your risk down to 1.8%
P Oh I see yes
HP … improves your life expectancy slightly, and
probably brings your Heart Age down a year.
So it is just you know showing that it can and
obviously, the lower you can keep these factors
that you influence, for longer, the better quality
of life and life expectancy there is … your risk is
going to increase slightly with age. So it is about
trying to moderate those other factors.
P So what impact does exercise have on that?
HP It has quite a significant impact on your cholesterol,
it does help your cholesterol a lot. We know that it
helps because that increases your good cholesterol,
which can help increase the balance so, that can
help with it as well.
P So what’s the normal range that is seen for
HDL cholesterol?
HP HDL can be anything from sort of 1.1 to about 2.5,
you don’t get much over, I can’t say I have seen
many, I have seen a few. But your cholesterol
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could be anything down to you know 3.5.
P OK and really bad would be?
HP 6 or 7’s, so would be sort of …
P Oh OK – so 5.6 is yeah it is edging up isn’t it?
(JBS3, 7_020, Male, 45)
The patient evaluated the threat and sought information
to facilitate their appraisal. Whilst positive, this exchange
again demonstrated misunderstanding of CVD event-free
survival age as life expectancy, this time from the practi-
tioner. The visual impact of demonstrating how CVD risk
can be reduced through risk factor modification (e.g., choles-
terol, smoking status) aided patient understanding and real-
istic threat appraisal. There were fewer examples of active
engagement during discussion of the CVD risk score within
QRISK®2 consultations, which may be due to the inability to
show risk factor modification when using the calculator.
Coping appraisal
References to coping appraisal were more common
among JBS3 (60, 94%) than QRISK®2 consultations (55,
86%). Communication of risk in JBS3 consultations were
not observed in the same way as QRISK2; with most
focussed on facilitators of adaptive coping (i.e., risk-
reducing changes that patients could make):
HP Erm and then this gives you your healthy year’s
outlook, so based on your current lifestyle your
risk of a heart attack or a stroke in the next 10
years is coming out at 2.4%. We aim for peo-
ples risk to be below 10% so that’s …
P Yeah.
HP … absolutely fine and on average you expected
to survive to an age of 84 without a heart attack
or stroke, so brilliant. So as I say your blood
pressure pretty good as it is you not going get
that much lower.
P No.
HP Diet wise would you say you got a pretty good
diet do you know the sorts of …
P We sort of grow our own vegetables and fruit
and stuff like that …
HP Yeah.
P … so erm I mean we eat reasonably healthy.
(JBS3, 7_044, Female, 54)
Following communication of the risk score, the practi-
tioner moved on to ways the patient could maintain a low
risk through identification of eating behaviours, suggesting
that whilst practitioners (from both groups) spent little
time talking about the CVD risk score, the additional risk
information available in JBS3 may have helped to facilitate
more risk factor discussion between the patient and prac-
titioner than when using QRISK®2.
Discussions around response costs for adaptive coping
(i.e. perceived costs associated with a recommended be-
haviour) related to use of statins or blood pressure medi-
cation were only observed in seven JBS consultations
(11%) and, not any QRISK®2 consultations.
HP Obviously we’ve tried them, and they haven’t
agreed with you.
P I tried the ***17,34 statin
HP Yeah, and there are other statins we can dis-
cuss and obviously benefits of those they can
reduce your cholesterol obviously and we can
reduce your risk of cardiovascular disease so it
might be worth having a think about and if
you want to just discuss that further or a dif-
ferent type of statin …
P All they did was it affected my reflux and it
made the reflux worse
HP Yeah
P So
HP Yeah
P I was on that and an Aspirin – I did the aspirin
first and then …
HP Yeah, but it was affecting you. I mean it might
be worth a having another … err you know a
think about whether you wanted to erm take
that, because obviously it would lower your
cholesterol, obviously add to a healthier heart
erm and reduce that risk of cardiovascular dis-
ease, but then obviously we’ll not gonna push that
onto you, err it is something you can talk to
myself, one of the doctor’s once you have
had time to think erm and they can advise
or XXX the prescribing nurse, because they
can prescribe, you know talk about you know
what’s best, which statin would be best, and
not all statins agree with everybody but
there might be one out there that actually
has a better erm compatibility with yourself
OK?
P Yeah
HP How do you feel about what I have told you
today?
P I would consider it.
(JBS3, 8_177, Male, 71)
Here, the patient’s prior engagement with statins as
a response cost was discussed between the patient
and the practitioner, leading to a re-evaluation of the
medical intervention by the patient. However, the pa-
tient’s concern regarding their previous experience of
taking statins was not well addressed. The practi-
tioner appeared to interrupt the patient to repeat the
benefits of statins. The perceived cost of taking
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statins also provided motivation to adopt risk-
promoting behaviours:
HP But well done!
P I am pleased about that yes.
HP That’s really good, no I am very pleased with
you because that’s really good. And where you
were at 10% just before, it is now 5%, so you
have halved the risk in that time. So that’s
really good. So it shows it can be done.
P Yeah, yeah and that’s what I would rather do
than taking tablets,
HP Of course
P I would rather think, no I know what’s wrong, I
will deal with it in time.
(QRISK®2 + Informatica, 12_055, Female, 64)
In a previous NHSHC (conducted 5 years prior), the
patient identified what was wrong and showed account-
ability for making health-related behavioural changes, “I
will deal with it”. However, opportunities to discuss
facilitators of adaptive coping were sometimes missed by
practitioners:
HP I look at your [total: HDL cholesterol] ratio
and your ratio is good. But just to keep a little
eye on it, maybe they will test it again in a
year’s time. You probably won’t be due this
Health Check, because your risk is only 3%,
which is low. It will increase as you age, so
your Health Check wouldn’t be due again for 5
years, but you could probably have your chol-
esterol done in about a year, with you know
normal bloods taken out of your arm. Erm
your Heart Age,
because you got such results in the green, your
Heart Age has come up less than your actual
age, but that’s with the 2 years added on from
being an ex-smoker.
P So is it possible that I could get that even lower,
if my cholesterol came down a lot.
HP Well we will have a look now, I will play about
with it. So if you had never smoked at all, your
Heart Age would be 45. If you were still smoking,
it could be 51. So being an ex-smoker tends to
add 2 years, so with your cholesterol, it could be
brought down to 46.
P Massively yeah.
(QRISK®2 + Informatica, 2_077, Male, 48)
The patient above attempted to understand how
their risk could be reduced. The practitioner did not
engage with this to encourage the risk-reducing be-
haviour or discuss ways to reduce cholesterol. Rather,
they proceeded to talk about the impact of previous
smoking status (which is unmodifiable) on CVD risk.
Whilst references to coping appraisal were more com-
mon among JBS3 consultations, again practitioners in
both groups appeared to focus more on the consult-
ation process than the patient.
Coping modes
Maladaptive coping
Maladaptive coping was classified when the patient ap-
peared to negatively engage in risk management discus-
sion with the practitioner and was dismissive of
suggestions (e.g., patient believes they have a sufficiently
healthy lifestyle and dismisses discussion about
change). As noted, patient responses to risk informa-
tion were often limited to single words. Where con-
text allowed, apparent non-engagement and minimal
verbal responses from patients were also interpreted
as maladaptive coping responses when the risk infor-
mation communicated by the practitioner did not
provoke a response from the patient (i.e., a monosyl-
labic response). Maladaptive coping was identified in
49 (77%) QRISK®2 consultations (coded 139 times;
average 3/consultation), compared to 40 (62.5%) JBS3
consultations (coded 110 times; average 3/per consult-
ation). Below, the practitioner briefly communicates
QRISK®2 before moving on to Heart Age (using
Informatica):
HP Yeah this is the screening I was telling you
about. So, your risk is 9%
P Right
HP Which is your key risk for you over the heart
disease and diabetes and stroke risk
P And heart disease
HP As you, as you age your risk does seem to
increase, erm any results that you’ve got in the
red tend to push up your Heart Age slightly
P Aha
HP So if we can get the results out of the red and
back into the green, that can reduce that one
down
P Right OK
HP So for example, being an ex-smoker actually
puts 2 years onto your Heart Age there.
P Yeah
HP So would be its 66 and it would be 66 if you
never smoked at all.
P Right.
HP Erm if you were still smoking it would be 73.
P Oh my gosh
HP Your Heart Age has come up as 71 – you are
69. Any results you have got in the red do tend
to increase your Heart Age. It is just that one
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cholesterol one that was in the red.
(QRISK®2 + Informatica, 2_001, Female, 66)
Sometimes maladaptive responses to the 10-year per-
centage risk score could be prompted into a more posi-
tive response through communication of Heart Age. The
brief exchange prior to the communication of Heart Age
may have also suggested that the practitioner was less
confident in discussing absolute risk, a recurrent
observation. If practitioners cannot clearly explain the
meaning of a patient’s percentage risk score to confer
understanding, subsequent discussion/actions regarding
risk management may be undermined.
Minimal engagement following communication of the
risk score was also identified in JBS3 consultations:
HP OK. And your blood pressure being under 82
but that’s fine everything is OK with that.
Now, on average what they’re saying is that
your risk of a heart attack or stroke in the next
10 years is 15%, again, that is down to the fact
that you smoke.
P Hm
HP OK.
P Sigh
HP And to expect to survive till the age of 78 with-
out a heart attack or a stroke OK. And if we
have a look at the next, this one, just reiterates
its this, but if I changed it to … say if you
didn’t smoke OK and we went to the next your
Heart Age would then become equal with your
age.
P Hm hm
HP And your risks in … of a heart attack or stroke
in the next 10 years comes down to 9.6% and
your actual survival to the age of 83 without a
heart attack or a stroke OK and that reiterates
it in that as well.
P Hm hm
HP OK so that’s the difference.
P Hm hm
P Hm hm
HP OK. Erm
P Cough
HP So it gives you food for thought.
P Hmm hmm. You haven’t told me anything I
didn’t already know.
(JBS3, 1_181, Male, 65)
The practitioner did not encourage the patient to quit
smoking nor did they explore any experience with previ-
ous attempts and therefore were unlikely to promote
intention to change behaviour. With an added pressure
of time within NHSHC consultations, adherence to the
process of completing the NHSHC may result in pa-
tients being passive recipients of information. As shown
above (and throughout), the practitioner delivered the
information presented on the screen without asking
questions to check understanding or provide context.
This resulted in little response from the patient which
may be indicative of deference to the practitioner’s
health knowledge and is, again, evidence of power
imbalance.
Negative engagement in discussion of risk factor man-
agement was also evident following the suggestion of
statin use:
HP What we do tend to say if you risk is above
10%, obviously I don’t know whether the doc-
tors have ever discussed a statin with you?
P I don’t see the point, I mean if I am going to live
to 83, I am quite happy to live to 83.
HP So it’s just about being aware that we know
that taking a statin can help reduce your over-
all risk, so it’s one that sort of we usually ad-
vise that …
P If we do this next time and I don’t know, it was
04 [last cholesterol check], and we are now in
2018, so what does that mean, it could be another
12 to 14 years [for the next Health Check]?
HP Well I do normally try and do these every 5
years, so yeah.
P So yes, if it is hugely worse
HP Yeah
P … in 5 years, I will consider it.
(JBS3, 7_012, Male, 70)
Again, the patient misinterpreted CVD event-free
survival age and suggested that their risk was not severe
enough to consider medical intervention in the short-
term; only if it was “hugely worse” in the next NHSHC.
This was another example of a missed opportunity for
the practitioner to question the patient’s understanding
of their risk and potential false reassurance provided by
the 10-year percentage risk score.
Adaptive coping
Adaptive coping was classified when the patient ap-
peared to positively engage with discussion of inter-
ventions to manage CVD risk; apparently listened to
and engaged in the consultation and accepted what
was being said/suggested. Adaptive coping was identi-
fied in 58 QRISK®2 (91%) consultations with (310
codes; average 5/consultation) and 55 JBS3 (86%) con-
sultations (328 codes; average 6/consultation). The fre-
quency of occurrences overall and per consultation
were similar between the two groups for adaptive cop-
ing in medical interventions [39 QRISK®2 (61%)
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consultations and 116 codes (average 3/consultation);
42 JBS3 (66%) consultations and 142 codes (average 3/
consultation)] and lifestyle changes [11 QRISK®2 (17%)
consultations and 15 codes (average 1/consultation);
20 JBS3 (31%) consultations and 32 codes (average 2/
consultation)]. A number of patients showed inten-
tions to change behaviour as a result of their CVD risk.
HP So your ratio is 3.5. So this is the screening I
was telling you about. So your risk is 3%. That
will increase as you age.
P Yeah
HP And obviously if we can, perhaps with your
smoking, it has pushed your Heart Age up to
48, and your age is 41. Because that is the only
result you have got in the red. Because all your
other results are really good, they are in the
green.
P They are really good, so I need to …
HP Yeah, so if you had never smoked at all, your
Heart Age would be aged 40.
P I think I need to do something about that don’t I?
(QRISK®2 + Informatica, 2_122, Male, 41)
Here is another example of how Heart Age changed
the way the patient responded to the information pre-
sented. Whilst a positive response was received, little
time was allowed to respond before the practitioner
moved on. Giving time for the patient to check their
understanding with the practitioner may have provided
opportunity for the patient to increase their confidence
in actively engaging with coping behaviours. Another
example of positive engagement during the discussion of
risk was also identified in another practice:
HP OK that’s good. Err let’s see your key risk.
P If I know what weight so I can just try to change
my life.
HP Yeah, yeah it would be good if you can cut
down and, and lose a bit of the weight err
what was it 13.8. So it’s only a little higher it
should ideally be below 10% is what we want
so 13.8 is a bit high but it is because of, be-
cause of your weight. OK you don’t smoke you
don’t drink
alcohol so that’ all good, but your waist is a
bit big as well.
P Yeah
HP Your waist is erm it’s 112 let’s have a look.
P Around my tummy around here.
HP Yeah let’s have a look. So your waist is 44 in..
P And that’s this bit here.
(QRISK®2, 3_259, Male, 57)
The patient above engaged in the information pre-
sented about their risk and suggested a need for weight
management, somewhat reinforced by the practitioner.
However, the interaction was disjointed, which may be a
result of the practitioner’s need to complete all elements
of the NHSHC and attending to what the patient is say-
ing, creating a barrier for adaptive coping. Whilst scarce,
a successful strategy for supporting adaptive coping used
by one practitioner was to ask the patient to reflect on
the risk information they had received, prompting con-
sideration of action needed:
HP So average survival free of heart attack or
stroke is 84.1 years OK? So how do you feel
about that?
P Oh I will make more of an effort to lose some
weight.
(JBS3, 1_154, Female, 70)
The approach adopted by the practitioner encouraged
the patient to express their immediate reaction to their
CVD risk, which gave the patient time to evaluate their
action and show intention to change their behaviour.
This was a rare example of the PMT in action; showing
connection between risk information and the patient’s
intention to change her behaviour, helping to redress
the power imbalance evident in most consultations
across both groups. It also demonstrated the significant
role the practitioner plays in ensuring risk communication
is delivered effectively regardless of the risk
calculator used.
Discussion
We report the first qualitative data from 128 video-
recorded NHSHCs to explore how practitioners use QRIS
K®2 and JBS3 to communicate CVD risk in the consult-
ation, and how patients respond to risk information. An
ecologically valid approach was used to compare usual
practice (QRISK2) with use of JBS3 following basic intro-
ductory training to familiarise practitioners with the tool
and features to use. This allowed a realistic study of how
practitioners would use JBS3 if it was made available,
without additional risk communication training, which is
generally not provided for NHSHC practitioners [4, 47].
Main findings in relation to our aims were, first, that
components of the PMT including threat appraisal, facilita-
tors of and response costs to adaptive coping were coded
more frequently in consultations using JBS3 (compared
with QRISK2). This suggests that JBS3 may provide more
opportunities to initiate risk factor discussion than QRIS
K2, possibly due to the risk factor modification function.
Second, CVD event-free survival age communicated in
JBS3, was misunderstood by both patients and practi-
tioners. Third, patients presented with a QRISK®2 score
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acknowledged their risk level, but it was unclear whether
they understood 10-year percentage risk (or trusted the
basis and relevance to them). Visual presentations of risk
and Heart age, found in JBS3 (not typically communicated
within standard practice systems - although can be gener-
ated in QRISK®2), appeared more impactful and aided
patient understanding, compared with QRISK®2. This is in
line with evidence that Heart Age is easier to understand
than 10-year percentage risk [29, 48] and visual displays are
preferable for promoting risk-reducing behaviour [30].
Regardless of the risk calculator used and despite the
recognised importance of risk communication in both
the NHSHC best practice guidance [3] and competence
framework [49], there was little discussion of CVD risk.
This was particularly marked in QRISK®2 consultations.
Practitioners often simply relayed the risk score, without
discussing the implications of the risk for the patient or
what they could do about it. Equally, most patients of-
fered minimal responses to the risk information, often
acknowledging with a single word. Practitioners may
have avoided confirming patient understanding if they
felt unable to explain the risk scores in more detail or
the pressure of time may have prevented further explor-
ation at the expense of the quality of risk communication.
This supports evidence that patients and practitioners
struggle to understand CVD risk and some practitioners
lack confidence in communicating the risk score [4, 17,
19–21] leading to poor patient recall of CVD risk, confu-
sion [22] and misunderstanding.
There was an apparent absence of active listening by
practitioners who frequently missed cues from patients
who were unclear about their risk score. Active listening
involves making a conscious effort to focus on what is
being said rather than passively ‘hearing’ the message,
and leads to improved levels of patient satisfaction and
greater adherence to treatment options [50]. By not pro-
viding additional information to patients that would
allow them to appraise their risk, practitioners are limiting
the opportunity for patients to show intent to engage in
risk reducing behaviours, thus encouraging a maladaptive
coping response. Best practice guidance [3] recommends
that practitioners use motivational interviewing (MI) to
encourage adherence to recommended treatment [51].
Motivational interviewing is a person-centred approach to
promote discussion with patients to resolve ambivalence
[52]. There was little to no evidence of MI techniques in
our 128 NHSHC consultations.
Limited patient responses and poor listening skills,
leading to practitioner dominance, were inferred from
quantitative analysis of the complete RICO study cohort
[n = 173 [41]]. These were confirmed here, with evidence
of missed opportunities to discuss patients’ intentions to
change behaviour. Missing these opportunities risks
undermining the purpose of the NHSHC; without
discussion of intervention practitioners are unlikely to
encourage patients to commit to engaging in risk-
reducing behaviours. The demands on practitioners to
complete all aspects of an NHSHC within a limited time
could lead to prioritisation of process over patient en-
gagement. The resulting practitioner-dominated consul-
tations are less patient-centred, and would be expected
to lead to low patient and practitioner satisfaction [53–
56], and poor patient outcomes, such as adherence to
clinical recommendations and health-promoting behav-
iour [57]. Where there was talk of risk-reducing behav-
iour, JBS3 appeared more effective than QRISK®2 in
promoting discussion of facilitators for adaptive coping,
perhaps due to additional functionality (i.e., manipula-
tion of risk). This suggests that other methods of com-
municating risk may be more suitable to promote
discussion around risk-reducing behaviour.
Implications for practice
The NHSHC programme is an ambitious non-
communicable disease prevention programme, the lar-
gest of its kind [4]. An evidence-based review of NHSH
C is underway to maximise the programme’s benefit in
the next decade, with likely changes to the universal
offer of in-person consultations in primary care [58].
Whilst changes to delivery are inevitable, elements of
the programme will still require practitioner-patient
consultation. Our findings show that certain functions of
JBS3 are useful for communicating CVD risk to patients,
and also highlighted important implications for NHSHC
practice in general:
 There is a clear training need among NHSHC
practitioners. There is an expectation that
practitioners ‘should be trained in communicating
the risk score and results to the client’ and that
‘methods, such as motivational interviewing
techniques, should engage clients in person-centred
conversations about their own reasons for change’
[49] (p21). Yet it is difficult for practitioners to meet
these requirements without necessary training and
ongoing support. Here, these skills were generally
not evident and we know from previous work that
practitioners responsible for delivering NHSHC
generally receive little (or no) training in CVD
risk communication and motivational interviewing
[22, 59, 60].
 Alongside training, there is also a need to prioritise
the quality of interaction over the process of the
consultation. Increasing the overall appointment
length or, perhaps more feasible, streamlining the
components of NHSHC would give practitioners
more time to engage patients in dialogue regarding
their CVD risk and its management. The minimal
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response from patients during the NHSHC
consultations made it difficult for us (and
practitioners) to gauge patient understanding and
intentions for health-promoting behaviour.
Positive outcomes were identified when practitioners
checked patient understanding, relayed information in a
way that was meaningful to the patient (e.g. Heart age)
and asked for patient feedback around the CVD risk
score. Practices included in the sample allocated 15–30
min per Health Check, but our quantitative evidence
showed consultations lasted as little as 6.8 min [41].
There is clearly a need to provide additional support
for practitioners. Measures to make consultations
more patient-focused and give practitioners the flexi-
bility to allow engagement in dialogue should be
explored.
Strengths and limitations
This is the first qualitative analysis to explore how risk is
communicated and how patients respond during video-
recorded NHSHC consultations, including comparison
of QRISK®2 and JBS3 CVD risk calculators. Strengths in-
clude video-recording of NHSHCs across a diverse range
of practices stratified by deprivation, with stratified sam-
pling of patients, a comprehensive coding approach and
a large sample (for qualitative analysis). Limitations are
recognised:
 The use of QRISK®2 + Informatica may have
enhanced these consultations. To maintain
ecological validity of ‘usual practice’, patients from
these practices were included in the main analysis
and has not altered our conclusions.
 Incorrect use of JBS3 (e.g., including communication
of CVD event-free survival) resulted in the exclusion
of several consultations which may have biased our
comparisons in favour of JBS3.
 Sparse discussion specifically around the risk score
and subsequent patient responses made it difficult to
apply the PMT framework effectively (the
theoretical framework required researchers to
classify patient responses as either positive or
negative). Thus, a third ‘neutral’ classification was
added to the framework to account for monosyllabic
responses (see Supplementary Material 2 for
examples). Yet following the PMT, the new category
still needed to be classified as one of the two coping
modes (i.e., adaptive or maladaptive). Moreover,
follow-up interviews with patients and practitioners
as part of the RICO study, will be analysed to
further explore their experiences, perceptions and
understanding of CVD risk and related intentions.
Conclusions
Analysis of video-recorded NHSHC consultations showed
sparse communication of CVD risk, particularly in consul-
tations supported by QRISK®2. Where risk was communi-
cated, patient responses were minimal and practitioners
missed opportunities to check patient understanding and
encourage risk-reducing behaviour. JBS3 appeared to
better promote opportunities to initiate risk-factor discus-
sion and Heart Age and visual representation of risk were
more easily understood and impactful than QRISK®2. The
apparent lack of effective CVD risk discussion in both
groups resulted in misunderstandings, practitioner-
dominated discussion and increased likelihood of a mal-
adaptive coping response. The NHSHC programme is
currently the largest CVD prevention initiative in England.
Whilst an evidence-based review of NHSHC is underway
[52], with likely changes to programme delivery, face to
face consultations are necessary to deliver key elements of
NHSHC. The analysis presented demonstrates the import-
ance of effective, shared practitioner-patient discussion for
enabling adaptive coping responses, only achievable
through solid practitioner understanding of the nature of
the information being shared and through effective train-
ing to deliver this information to patients [60].
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